A Time for MYC: Metabolism and Therapy

Area of Science:

• Oncology
• Molecular Biology
• Chronobiology

Background:

• The MYC oncogene is frequently deregulated in human cancers, driving uncontrolled cell growth.
• MYC dysregulation alters cellular metabolism and disrupts the normal circadian rhythm controlled by Bmal1-Clock proteins.
• This disruption leads to a metabolic state that supports cancer cell proliferation.

Purpose of the Study:

• To investigate the intricate relationship between MYC oncogene activity, cellular metabolism, and the circadian clock in cancer.
• To identify potential therapeutic targets and strategies based on these interactions.

Main Methods:

• Analysis of MYC's role in transcriptional imbalance and its impact on metabolic pathways.
• Examination of MYC's interaction with the Bmal1-Clock circadian circuitry.
• Assessment of nutrient dependency in MYC-driven cancer cells and the role of enzymes like LDHA and GLS.

Main Results:

• Deregulated MYC promotes a constitutive growth program, activating mTOR and increasing nutrient dependency.
• MYC suppresses the circadian clock, potentially suspending Bmal1-Clock's inhibitory effect on metabolism.
• Key metabolic enzymes (LDHA, GLS) are identified as potential therapeutic targets.

Conclusions:

• MYC-driven cancer cells exhibit altered metabolism and a disrupted circadian clock, creating vulnerabilities.
• Targeting metabolic pathways, possibly with chronotherapy, could be effective against cancer.
• Timing metabolic interventions may enhance anti-tumor efficacy and reduce side effects in normal tissues.